Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismPaul M. Ridker, Robert J. Glynn, Samuel Z. Goldhaber et al.|New England Journal of Medicine|2003Cited by 809
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J. Rhodes, Stefano Ghio, Ken Batai et al.|The Lancet Respiratory Medicine|2018Cited by 212
The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary HypertensionΕ. Kenneth Weir, Margaret Wu, Roberta M. Goldring et al.|American Review of Respiratory Disease|1989Cited by 188
Defining the clinical validity of genes reported to cause pulmonary arterial hypertensionCarrie L. Welch, David Langleben, Micheala A. Aldred et al.|Genetics in Medicine|2023Cited by 73